Related Experiment Video
Updated: Nov 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy in an extremely preterm infant.
Apoorva Aiyengar1, Claire Howarth2, Sujith Pereira2
1Neonatal Unit, Homerton University Hospital NHS Foundation Trust, London, UK a.aiyengar@nhs.net.
This case study discusses hypertrophic cardiomyopathy (HCM) in an extremely preterm infant. It highlights the challenges in diagnosing the cause of neonatal HCM, considering factors like patent ductus arteriosus (PDA) and steroid exposure.
Area of Science:
- Neonatal Cardiology
- Pediatric Cardiology
- Perinatology
Background:
- Extreme prematurity (24-week gestation) presents unique challenges in neonatal care.
- Neonatal hypertrophic cardiomyopathy (HCM) has diverse etiologies, including genetic, metabolic, endocrine, and medication-induced factors.
- Patent ductus arteriosus (PDA) is common in preterm infants and can lead to cardiac remodeling mimicking HCM.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

